Europe – EMA Management Board: highlights of June 2022 meeting
At its 16 June 2022 meeting in Amsterdam, the European Medicines Agency's (EMA) Management Board elected Christelle Ratignier-Carbonneil as vice-Chair of the Board for a three-year...
USA – FDA authorizes Pfizer, Moderna vaccines for youngest children
The US Food and Drug Administration (FDA) on Friday authorized the emergency use of Moderna and Pfizer-BioNTech’s COVID-19 vaccines for children as young as...
Europe – Start of rolling review for adapted Spikevax COVID-19 vaccine
EMA has started a rolling review for a version of Spikevax adapted to provide better protection against specific variants of SARS-CoV-2, the virus that...
UK – NICE recommends Eli Lilly’s breast cancer therapy
Eli Lilly has announced that Verzenios – also known as abemaciclib – in combination with endocrine therapy, has been recommended by the National Institute...
UK – Genedrive genetic variant test for infants evaluated by NICE
Genedrive – the near patient molecular diagnostics company – has revealed that the National Institute for Health and Care Excellence (NICE) has started an...
UK – MHRA joins international partnerships to set global standards for medicines and medical...
The UK is set to play a greater international role in making sure medicines and medical devices are regulated safely and efficiently worldwide, the...
Europe – Start of rolling review for adapted Comirnaty COVID-19 vaccine
EMA has started a rolling review for a version of Comirnaty adapted to provide better protection against a specific variant or variants of SARS-CoV-2,...
Europe – Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2022
Update on review of cases of heavy menstrual bleeding with mRNA COVID-19 vaccines
The PRAC is continuing its assessment of cases of heavy menstrual bleeding (heavy periods)...
Europe – EMA recommends withdrawal of marketing authorisation for amfepramone medicines
EMA’s safety committee (PRAC) has recommended the withdrawal of EU marketing authorisations for amfepramone obesity medicines.
The recommendation follows a review which found that measures to restrict...
France – Intérêt du logiciel doté d’IA « PharmaClass » pour aider le pharmacien clinicien à...
LILLE (TICsanté) - Le logiciel "PharmaClass", qui utilise l'intelligence artificielle (IA), aide le pharmacien clinicien à sécuriser la prise en charge médicamenteuse à l'hôpital,...
